Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva Colobreathe® is an inhaled antibiotic for the management of chronic Pseudomonas aeruginosa infections in...